SEC Filings | NeuroBo Pharmaceuticals, Inc.

Filing date	Form	Description	Filing Group	View
Feb 1, 2023	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	Registration Statements	0001104659-23-009350.rtf 0001104659-23-009350.xls 0001104659-23-009350.pdf View HTML
Jan 31, 2023	EFFECT	EFFECT	Other	9999999995-23-000244.rtf 9999999995-23-000244.xls 9999999995-23-000244.pdf View HTML
Jan 27, 2023	CORRESP	CORRESP	Other	0001104659-23-007453.rtf 0001104659-23-007453.xls 0001104659-23-007453.pdf View HTML
Jan 25, 2023	UPLOAD	UPLOAD	Other	0000000000-23-000829.rtf 0000000000-23-000829.pdf View HTML
Jan 23, 2023	S-3	Simplified registration form	Registration Statements	0001104659-23-005852.rtf 0001104659-23-005852.xls 0001104659-23-005852.pdf View HTML
Jan 18, 2023	8-K	Report of unscheduled material events or corporate event	Current Reports	0001104659-23-004461.rtf 0001104659-23-004461.xls 0001104659-23-004461.pdf View HTML
Jan 18, 2023	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	0001962139-23-000001.rtf 0001962139-23-000001.xls 0001962139-23-000001.pdf View HTML
Dec 30, 2022	SC 13D/A	An amendment to a SC 13D filing	Other	0000899140-22-000848.rtf 0000899140-22-000848.xls 0000899140-22-000848.pdf View HTML
Dec 22, 2022	8-K	Report of unscheduled material events or corporate event	Current Reports	0001104659-22-129589.rtf 0001104659-22-129589.xls 0001104659-22-129589.pdf View HTML
Nov 28, 2022	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	Proxy Filings	0001140361-22-043315.rtf 0001140361-22-043315.xls 0001140361-22-043315.pdf View HTML

Data provided by Kaleidoscope.